DK0964863T3 - Oxazolidinoner som 5-HT2A-antagonister - Google Patents

Oxazolidinoner som 5-HT2A-antagonister

Info

Publication number
DK0964863T3
DK0964863T3 DK98909397T DK98909397T DK0964863T3 DK 0964863 T3 DK0964863 T3 DK 0964863T3 DK 98909397 T DK98909397 T DK 98909397T DK 98909397 T DK98909397 T DK 98909397T DK 0964863 T3 DK0964863 T3 DK 0964863T3
Authority
DK
Denmark
Prior art keywords
oxazolidinones
ht2a antagonists
ht2a
antagonists
Prior art date
Application number
DK98909397T
Other languages
Danish (da)
English (en)
Inventor
Henning Boettcher
Helmut Pruecher
Helmut Greiner
Gerd Bartoszyk
Christoph Seyfried
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK0964863T3 publication Critical patent/DK0964863T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK98909397T 1997-02-26 1998-02-06 Oxazolidinoner som 5-HT2A-antagonister DK0964863T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19707628A DE19707628A1 (de) 1997-02-26 1997-02-26 Oxazolidinone
PCT/EP1998/000637 WO1998038189A1 (de) 1997-02-26 1998-02-06 Oxazolidinone als 5-ht2a-antagonisten

Publications (1)

Publication Number Publication Date
DK0964863T3 true DK0964863T3 (da) 2003-08-04

Family

ID=7821498

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98909397T DK0964863T3 (da) 1997-02-26 1998-02-06 Oxazolidinoner som 5-HT2A-antagonister

Country Status (25)

Country Link
US (1) US6462056B1 (ru)
EP (1) EP0964863B1 (ru)
JP (2) JP4402175B2 (ru)
KR (1) KR20000075697A (ru)
CN (1) CN1177847C (ru)
AR (1) AR010899A1 (ru)
AT (1) ATE240954T1 (ru)
AU (1) AU739251B2 (ru)
BR (1) BR9807765A (ru)
CA (1) CA2281918C (ru)
CZ (1) CZ299199A3 (ru)
DE (2) DE19707628A1 (ru)
DK (1) DK0964863T3 (ru)
ES (1) ES2197466T3 (ru)
HU (1) HUP0001093A3 (ru)
ID (1) ID22838A (ru)
NO (1) NO313415B1 (ru)
PL (1) PL335100A1 (ru)
PT (1) PT964863E (ru)
RU (1) RU2196140C2 (ru)
SK (1) SK112799A3 (ru)
TW (1) TW531538B (ru)
UA (1) UA58542C2 (ru)
WO (1) WO1998038189A1 (ru)
ZA (1) ZA981579B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787328A1 (fr) * 1998-12-22 2000-06-23 Sanofi Sa Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
AU771234B2 (en) * 1999-01-28 2004-03-18 Bristol-Myers Squibb Company Antidepressant heterocyclic compounds
ES2165274B1 (es) 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AU5567000A (en) 1999-06-24 2001-01-09 Toray Industries, Inc. Alpha1b-adrenergic receptor antagonists
GB9928568D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
DE60212959T2 (de) * 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
JPWO2004069828A1 (ja) * 2003-02-04 2006-05-25 三菱ウェルファーマ株式会社 ピペリジン化合物およびその医薬用途
EP1691811B1 (en) 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CL2008001002A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CN101903380B (zh) * 2007-12-18 2013-04-17 埃科特莱茵药品有限公司 5-氨基环甲基-噁唑啶-2-酮衍生物
ES2628091T3 (es) * 2008-10-10 2017-08-01 Idorsia Pharmaceuticals Ltd Antibióticos de oxazolidinilo
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
DE4005371A1 (de) * 1990-02-21 1991-08-22 Merck Patent Gmbh Oxazolidinone
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
DK152090D0 (da) * 1990-06-22 1990-06-22 Lundbaek A S H Piperidylsubstituerede indolderivater
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
DE4324393A1 (de) 1993-07-21 1995-01-26 Merck Patent Gmbh 4-Aryloxy- und 4-Arylthiopiperidinderivate
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
ZA954689B (en) * 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
DE19500689A1 (de) 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate

Also Published As

Publication number Publication date
TW531538B (en) 2003-05-11
JP2009256363A (ja) 2009-11-05
PT964863E (pt) 2003-10-31
CA2281918C (en) 2007-04-03
JP2001513764A (ja) 2001-09-04
WO1998038189A1 (de) 1998-09-03
UA58542C2 (ru) 2003-08-15
EP0964863B1 (de) 2003-05-21
ATE240954T1 (de) 2003-06-15
HUP0001093A2 (hu) 2001-06-28
KR20000075697A (ko) 2000-12-26
JP4402175B2 (ja) 2010-01-20
CA2281918A1 (en) 1998-09-03
PL335100A1 (en) 2000-04-10
BR9807765A (pt) 2000-02-22
ID22838A (id) 1999-12-09
NO994106D0 (no) 1999-08-25
ZA981579B (en) 1999-03-17
DE59808461D1 (de) 2003-06-26
NO994106L (no) 1999-10-19
NO313415B1 (no) 2002-09-30
AU739251B2 (en) 2001-10-04
US6462056B1 (en) 2002-10-08
DE19707628A1 (de) 1998-08-27
CZ299199A3 (cs) 1999-11-17
RU2196140C2 (ru) 2003-01-10
AU6394998A (en) 1998-09-18
EP0964863A1 (de) 1999-12-22
SK112799A3 (en) 2000-06-12
HUP0001093A3 (en) 2001-07-30
CN1177847C (zh) 2004-12-01
AR010899A1 (es) 2000-07-12
CN1248973A (zh) 2000-03-29
ES2197466T3 (es) 2004-01-01

Similar Documents

Publication Publication Date Title
IT1308096B1 (it) Convertiplano
NO20015366L (no) Piperazinderivater som er anvendbare som CCR5-antagonister
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
NO985225L (no) Indolderivater nyttige som endotelinreseptorantagonister
DK1379522T3 (da) Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO991384D0 (no) Substituerte heterocykler som anti-tumormidler
DK1068202T3 (da) 1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister
DK1021541T3 (da) Aminoterminalt trunkeret MCP-2 som chemokinantagonister
DK1027342T3 (da) Cyclopentenderivater som motilinreceptorantagonister
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
DK1181288T3 (da) Bicycliske oxazolidinoner som antibakterielle midler
DK1086093T3 (da) Tetrahydroquinolinderivater som glycinantagonister
DK1075471T3 (da) Idolylderivater som serotonerge midler
NO992066D0 (no) Piperazinoderivater som neurokininantagonister
DK1119571T3 (da) Tricykliske Delta 3 piperidiner som alpha 2 antagonister.
NO20000434D0 (no) Lyksofuranosyl benzimidazoler som antivirale midler
NO993812L (no) (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler
NO995782L (no) Kvarternaere ammoniumforbindelser som tachykinin-antagonister
NO996244D0 (no) Pyrrolidinkarboksylsyrederivater som endotelinantagonister
NO20002575D0 (no) Substituerte oksimer som neurokininantagonister
DK0944601T3 (da) Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
NO20005756L (no) Karboksysubstituerte karboksamidderivater som tachykininantagonister
NO20021249L (no) Tienoisoksazolfenoksyusubstituerte etyl- og propylderivater anvendbare som D4antagonister